Larissa M Bomfim Selected Research

6-methyl-2-thiouracil

1/2019

Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larissa M Bomfim Research Topics

Disease

4	Neoplasms (Cancer) 10/2021 - 08/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 03/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021
1	Leukemia 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Acute Promyelocytic Leukemia 01/2019

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2019
2	CaspasesIBA 01/2019 - 01/2019
2	RutheniumIBA 01/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
1	tingenoneIBA 10/2021
1	ThioredoxinsIBA 10/2021
1	TriterpenesIBA 10/2021
1	tingenin BIBA 10/2021
1	6-methyl-2-thiouracilIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Biological ProductsIBA 01/2019
1	Concanavalin AIBA 01/2019
1	PlatinumIBA 01/2019
1	UracilIBA 01/2019
1	Volatile Oils (Essential Oils)IBA 03/2016
1	Kaurane DiterpenesIBA 08/2014
1	DiterpenesIBA 08/2014